4Lindsay R,Gallagher JC,Kleerekoper M,et al.Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.JAMA,2002,287:2668-2676.
5Rossouw JE,Anderson GL,Prentice RL,et al.The Women's Health Initiative Investigators.Risk and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial.JAMA,2002,288:321-333.
6Anderson GL,Limacher M,Assaf AR,et al.The Women's Health Initiative Steering Committee.Effects of conjugated equine estrogen in postmenopausal women with hysterectomy.JAMA,2004,291:1701-1712.
7O' Connel M.Hormones and gynecological malignancy.Med Forum Intern,2000,5:22-23.
8Weaver K.Estrogen therapy in women at risk of breast cancer.Med Forum Intern,2001,6:21-22.
9Hulley S,Grady D,Bush T,et al.The Heart and Estrogen/progestin Replacement Study (HERS) Research Group.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.JAMA,1998,280:605-613.
10Grady D,Herrington D,Bittner V,et al.The HERS Research Group.Cardiovascular disease outcomes during 6.8 years of hormone therapy:Heart and Estrogen/progestin Replacement Study follow-up (HERS Ⅱ).JAMA,2002,288:49-57.
